Specialist laboratory networks as preparedness and response tool - the Emerging Viral Diseases-Expert Laboratory Network and the Chikungunya outbreak, Thailand, 2019.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 16 12 2020
Statut: ppublish

Résumé

We illustrate the potential for specialist laboratory networks to be used as preparedness and response tool through rapid collection and sharing of data. Here, the Emerging Viral Diseases-Expert Laboratory Network (EVD-LabNet) and a laboratory assessment of chikungunya virus (CHIKV) in returning European travellers related to an ongoing outbreak in Thailand was used for this purpose. EVD-LabNet rapidly collected data on laboratory requests, diagnosed CHIKV imported cases and sequences generated, and shared among its members and with the European Centre for Disease Prevention and Control. Data across the network showed an increase in CHIKV imported cases during 1 October 2018-30 April 2019 vs the same period in 2018 (172 vs 50), particularly an increase in cases known to be related to travel to Thailand (72 vs 1). Moreover, EVD-LabNet showed that strains were imported from Thailand that cluster with strains of the ECSA-IOL E1 A226 variant emerging in Pakistan in 2016 and involved in the 2017 outbreaks in Italy. CHIKV diagnostic requests increased by 23.6% between the two periods. The impact of using EVD-LabNet or similar networks as preparedness and response tool could be improved by standardisation of the collection, quality and mining of data in routine laboratory management systems.

Identifiants

pubmed: 32265004
doi: 10.2807/1560-7917.ES.2020.25.13.1900438
pmc: PMC7140599
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS Pathog. 2007 Dec;3(12):e201
pubmed: 18069894
Euro Surveill. 2018 May;23(22):
pubmed: 29871722
Virus Genes. 2014 Dec;49(3):485-9
pubmed: 25113745
New Microbes New Infect. 2018 Mar 28;24:14-16
pubmed: 29707212
Travel Med Infect Dis. 2014 Mar-Apr;12(2):159-66
pubmed: 24291263
Genome Announc. 2017 Dec 7;5(49):
pubmed: 29217791
New Microbes New Infect. 2017 Jun 01;19:13-14
pubmed: 28663798
PLoS One. 2018 Dec 21;13(12):e0208896
pubmed: 30576334
Euro Surveill. 2017 Sep;22(39):
pubmed: 29019313
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862335
Euro Surveill. 2015 Apr 30;20(17):
pubmed: 25955774
Emerg Infect Dis. 2014 Aug;20(8):1404-6
pubmed: 25061989
Open Forum Infect Dis. 2018 Dec 12;6(1):ofy321
pubmed: 30697571
J Clin Virol. 2016 Mar;76:55-65
pubmed: 26828561
Euro Surveill. 2019 Mar;24(11):
pubmed: 30892179
J Clin Microbiol. 2017 Nov;55(11):3219-3226
pubmed: 28835479
Lancet. 2007 Dec 1;370(9602):1840-6
pubmed: 18061059
Clin Microbiol Infect. 2018 Mar;24(3):221-228
pubmed: 29274465
Emerg Infect Dis. 2011 May;17(5):910-3
pubmed: 21529410
Euro Surveill. 2017 Sep;22(39):
pubmed: 29019306

Auteurs

Giulietta Venturi (G)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Stephan W Aberle (SW)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Tatjana Avšič-Županc (T)

Institute of Microbiology and Immunology, Faculty of Medicine, Ljubljana, Slovenia.

Luisa Barzon (L)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Christoph Batejat (C)

Laboratory for Urgent Response to Biological Threats (CIBU), Institut Pasteur, Paris, France.

Elisa Burdino (E)

Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, Turin, Italy.

Fabrizio Carletti (F)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Rémi Charrel (R)

Unité des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IRBA, IHU Méditerranée Infection), Marseille, France.

Iva Christova (I)

National Reference Vector-borne pathogens Laboratory, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Jeff Connell (J)

National Virus Reference Laboratory, University College Dublin, Ireland.

Victor Max Corman (VM)

Department of Virology, Labor Berlin, Charité-Vivantes GmbH, Berlin, Germany.
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Mary Emmanouil (M)

Diagnostic Services Laboratory, Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.

Anne J Jääskeläinen (AJ)

Virology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Ivan Kurolt (I)

Research unit, University Hospital for Infectious Diseases 'Dr. Fran Mihaljević', Zagreb, Croatia.

Yaniv Lustig (Y)

Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Miguel J Martinez (MJ)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Marion Koopmans (M)

Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.

Orsolya Nagy (O)

Department of Virology, National Public Health Center, Budapest, Hungary.

Trung Nguyen (T)

Département de Microbiologie, Laboratoire national de santé, Luxemburg.

Anna Papa (A)

Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Mercedes Pérez-Ruiz (M)

Servicio de Microbiología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria, Granada, Spain.

Martin Pfeffer (M)

Institute of Animal Hygiene and Veterinary Public Health, Leipzig, Germany.

Jelena Protic (J)

National Reference Laboratory for ARBO viruses and haemorrhagic fever, Belgrade, Serbia.

Johan Reimerink (J)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Giada Rossini (G)

Regional Reference Centre for Microbiological Emergencies (CRREM), Unit of Clinical Microbiology, St Orsola Malpighi Hospital, Bologna, Italy.

María Paz Sánchez-Seco Fariñas (MP)

Centro Nacional de Microbiología. Instituto de Salud Carlos III, Madrid, España.

Jonas Schmidt-Chanasit (J)

WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Sandra Söderholm (S)

Department of Microbiology, The Public Health Agency of Sweden, Solna, Sweden.

Bertrand Sudre (B)

European Centre for Disease Prevention and Control, Solna, Sweden.

Marjan Van Esbroeck (M)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
The members of the CHIKV-Working Group are listed at the end of the article.

Chantal B Reusken (CB)

Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH